Intriguingly, although ESCA had the highest number of SCNAs (Fig. 1), none of the genes harbored prognostic information, suggesting that alterations in AMPK signaling components have minimal roles in driving tumor progression and patient outcomes. The gene discussed is PRKAA1; the disease is neoplasm.